Panel Discussion: Changing the Face of Cell Therapies with In Vivo Gene Engineering
Time: 3:00 pm
day: Day 1 – Track A – Afternoon
- Exploring the potential to develop a universal cell therapy without ex vivo isolation/expansion of T-cells
- How can we improve safety, dosing and efficacy by using mRNA to create CAR-T cells in vivo?
- Discussing how to control the pharmacokinetic properties of the cell product